“…All cases had progressive deterioration, fulfilling the first criteria for bvFTD according to 2011 criteria [10] ; 14 cases had 3 or more of 6 clinically discriminating features, fulfilling the criteria for possible bvFTD [3, 6, 7, 10-12, 18, 20, 23, 27, 28, 33, 36] ; 9 cases had 3 features [6,7,18,20,23,27,33,36] , 4 cases had 4 features [3,11,12,28] and our case had 5 features. Of these 14 cases, 6 went on to fulfill criteria for probable bvFTD with imaging consistent with bvFTD (frontal and/or temporal atrophy on CT or MRI, or frontal hypoperfusion or hypometabolism on SPECT or PET) and significant functional decline [7,10,12,23,28,33] . These cases also fulfilled the requirement for possible or probable bvFTD diagnoses that other non-degenerative nervous system, medical or psychiatric disorders could not better account for the disease, and the requirement for probable bvFTD diagnosis that biomarkers indicative of another neurodegenerative process were absent [10] .…”